Literature DB >> 20144956

A crucial role of nitric oxide in acute lung injury secondary to the acute necrotizing pancreatitis.

Shi Cheng1, Wen-Mao Yan, Bin Yang, Jing-dong Shi, Mao-min Song, Yuqian Zhao.   

Abstract

To investigate the role of nitric oxide (NO) in acute lung inflammation and injury secondary to acute necrotizing pancreatitis (ANP), 5% sodium taurocholate was retrogradely injected into the biliopancreatic duct of rats to ANP model. These ANP rats were given L-Arginine (L-Arg, 100 mg/kg), L-NAME (10 mg/kg), or their combination by intraperitoneal injection 30 min prior to ANP induction. At 1, 3, 6, and 12 hours after ANP induction, lung NO production, and inducible NO synthase (iNOS) expression were measured. Lung histopathological changes, bronchoalveolar lavage (BAL) protein concentration, proinflammatory mediators tumor necrotic factor alpha (TNF-alpha), and lung tissue myeloperoxidase (MPO) activity were examined. Results showed that NO production and iNOS mRNA expression in alveolar macrophages (AMs) were significantly increased along with significant increases in lung histological abnormalities and BAL proteins in the ANP group, all of which were further enhanced by pretreatment with L-Arg and attenuated by pretreatment with L-NAME, respectively. These markers were slightly attenuated by pretreatment with combination of L-Arg + L-NAME, suggesting that NO is required for initiating the acute lung damage in ANP rats, and also that L-Arg-enhanced lung injury is mediated by its NO generation rather than its direct effect. MPO activity and TNF-alpha expression in lung were upregulated in the ANP rats and further enhanced by pretreatment with L-Arg and attenuated by pretreatment with L-NAME, respectively. These results suggest that overproduction of NO mediated by iNOS in the lung is required for the acute lung inflammation and damage secondary to ANP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20144956     DOI: 10.1177/0960327110361760

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  7 in total

1.  Effect of tiron on remote organ injury in rats with severe acute pancreatitis induced by L-arginine.

Authors:  Hayam Ateyya; Heba M Wagih; Nagla A El-Sherbeeny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-27       Impact factor: 3.000

2.  Pleurotus eryngii Ameliorates Lipopolysaccharide-Induced Lung Inflammation in Mice.

Authors:  Junya Kawai; Tsugunobu Andoh; Kenji Ouchi; Satoshi Inatomi
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-01       Impact factor: 2.629

3.  Treatment with ginkgo biloba extract protects rats against acute pancreatitis-associated lung injury by modulating alveolar macrophage.

Authors:  Xiao-Wu Xu; Xiao-Min Yang; Yong-Heng Bai; Yan-Rong Zhao; Gong-Sheng Shi; Jian-Guo Zhang; Yi-Hu Zheng
Journal:  Prz Gastroenterol       Date:  2014-03-01

4.  ACVIM consensus statement on pancreatitis in cats.

Authors:  Marnin A Forman; Joerg M Steiner; P Jane Armstrong; Melinda S Camus; Lorrie Gaschen; Steve L Hill; Caroline S Mansfield; Katja Steiger
Journal:  J Vet Intern Med       Date:  2021-02-15       Impact factor: 3.333

5.  Emodin Ameliorates Acute Pancreatitis-Associated Lung Injury Through Inhibiting the Alveolar Macrophages Pyroptosis.

Authors:  Xiajia Wu; Jiaqi Yao; Qian Hu; Hongxin Kang; Yifan Miao; Lv Zhu; Cong Li; Xianlin Zhao; Juan Li; Meihua Wan; Wenfu Tang
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

6.  Determination of iNOS-2087A>G Polymorphism in Acute Pancreatitis Patients.

Authors:  V Pădureanu; Ioana StreaȚă; M Ioana; V Șurlin; E F Georgescu; Cristina Mărginean; A Săftoiu
Journal:  Curr Health Sci J       Date:  2014-12-14

Review 7.  Genetic Polymorphisms: A Novel Perspective on Acute Pancreatitis.

Authors:  Yong Chen; Chao Lian Xie; Ran Hu; Cheng Yi Shen; Mei Zeng; Chang Qiang Wu; Tian Wu Chen; Chen Chen; Meng Yue Tang; Hua Dan Xue; Zheng Yu Jin; Xiao Ming Zhang
Journal:  Gastroenterol Res Pract       Date:  2017-12-03       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.